Literature DB >> 32139890

Author Correction: China's response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response.

John Nkengasong1.   

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Entities:  

Year:  2020        PMID: 32139890      PMCID: PMC7095842          DOI: 10.1038/s41591-020-0816-5

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


Correction to: Nature Medicine 10.1038/s41591-020-0771-1, published online 27 January 2020. In the version of this article initially published, the date (year) was incorrect (10 January 2010) in the penultimate sentence of the first paragraph of the third subsection (‘Why Africa should be prepared’). The correct date is 10 January 2020. The error has been corrected in the HTML and PDF versions of the article.
  3 in total

1.  Drug Repurposing of Itraconazole and Estradiol Benzoate against COVID-19 by Blocking SARS-CoV-2 Spike Protein-Mediated Membrane Fusion.

Authors:  Chan Yang; Xiaoyan Pan; Yuan Huang; Chen Cheng; Xinfeng Xu; Yan Wu; Yunxia Xu; Weijuan Shang; Xiaoge Niu; Yihong Wan; Zhaofeng Li; Rong Zhang; Shuwen Liu; Gengfu Xiao; Wei Xu
Journal:  Adv Ther (Weinh)       Date:  2021-02-22

2.  Appraisal of China's Response to the Outbreak of COVID-19 in Comparison With SARS.

Authors:  Jiajia Li; Shixue Li; Wuchun Cao; Zhongli Wang; Zhuohui Liang; Wenhao Fu; Jinfeng Zhao
Journal:  Front Public Health       Date:  2021-07-07

3.  Measures Undertaken in China to Avoid COVID-19 Infection: Internet-Based, Cross-Sectional Survey Study.

Authors:  Yu Huang; Qingqing Wu; Ping Wang; Yan Xu; Lei Wang; Yusui Zhao; Dingming Yao; Yue Xu; Qiaohong Lv; Shuiyang Xu
Journal:  J Med Internet Res       Date:  2020-05-12       Impact factor: 5.428

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.